Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer
Go back to Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer| (NASDAQ: NTLA) | Delayed: 13.28 +1.68 (14.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.60 | 52 Week High | $30.40 | |||
| Open | $12.10 | 52 Week Low | $11.86 | |||
| Day High | $13.35 | P/E | N/A | |||
| Day Low | $12.01 | EPS | $0.00 | |||
| Volume | 6,112,132 | |||||

